In 2025, Rx/reimbursement adult incontinence in Slovakia recorded continued positive sales growth, with volume reaching 258.5 million units and a year-on-year increase of 1%. The category experienced strong current value growth of 5%, with sales rising to EUR81.6 million. This robust growth trajectory was driven primarily by a combination of demographic and regulatory factors, while, globally, the category’s expansion aligns with trends in ageing populations and rising demand for medical incont
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Slovakia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Slovakia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Rx/Reimbursement adult incontinence in Slovakia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Rx/Reimbursement adult incontinence in Slovakia?
- Which are the leading brands in Rx/Reimbursement adult incontinence in Slovakia?
- How are products distributed in Rx/Reimbursement adult incontinence in Slovakia?
- How is the rise of e-commerce changing the retail and competitive landscape?
- How has COVID-19 impacted demand? Where have sales increased due to stockpiling amidst national lockdown?
- How have enforced home seclusion and social distancing measures following COVID-19 changed usage patterns for Rx/Reimbursement adult incontinence products?
- Where is future growth expected to be most dynamic?
- How important will sustainability and recycling be in generating future growth?
Rx/Reimbursement Adult Incontinence in Slovakia - Category analysis
Key Data Insights
Value Growth Boosted by Premium Launches
Value Growth Boosted by Premium Launches
Rising Elderly Population Drives Demand for Convenient High-Absorption Solutions
Government Vat Cut Sparks Premium Innovation and Product Accessibility
Rising Patient Numbers to Prompt Stricter Reimbursement Oversight
Electronic Prescription Roll-Out Will Improve Patient Access and Tracking
Product Categorisation Reforms to Drive Tighter Clinical Alignment
Pharmacies Maintain Dominance as E-Commerce Enables Broader Access
Tissue and Hygiene in Slovakia - Industry Overview
Shift Towards Higher-Priced, Better-Quality Products Drives Value Growth
Key Data Insights
Shift Towards Higher-Priced, Better-Quality Products Drives Value Growth
SHP Harmanec Meets Urban Demand with Compact Toilet Paper Innovation
Celltex Elevates Wellness with Skin-Friendly Bella Herbs Pantyliners
Packaging Redesigns to Prioritise Ageing Consumers and Functional Wellness
Retail Tissue Will Retain the Lead as Value Growth Outpaces Volume
Wellness-Focused Innovation and Demographic Shifts to Reshape Future Demand
Procter & Gamble Adapts Premium Positioning as Rivals Close Share Gap
Shp Harmanec Leverages Eco-Initiatives to Strengthen Consumer Loyalty
Hartmann-Rico Accelerates Sustainable Shift with Reusable Underwear Launch
Hypermarkets and Supermarkets Anchor Bulk Routines as E-Commerce Accelerates
Retail E-Commerce Captures High-Value Growth through Convenience and Logistics
Health and Beauty Specialists Expand Premium Wellness with Sustainability Focus
Country Reports Disclaimer
Rx/Reimbursement adult incontinence
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!